ITGB4 and neoplasm: In conclusion, our study reveals the luminal-associated transcriptional program (FOXA1-EHF-ITGB4) with FOXA1 as the core regulator, as well as its downstream pathway (ECM-receptor interaction), which affects immune communication, mucus production, and tumor risk in IMA.